drugset / Trial / NCT00003956
Combination Chemotherapy in Treating Patients With Advanced Cancer
Phase 1
Completed
25 enrolled
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase I trial to study the effectiveness of SCH 66336, fluorouracil, and leucovorin in treating patients who have advanced cancer.
Timeline
- Start
- 1999-04
- Primary completion
- 2001-01
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leucovorin | Small molecule | — | Intravenous |
| Subject | Lonafarnib | Small molecule | — | Oral |
| Subject | fluorouracil | Small molecule | — | Intravenous |